Systems and solutions that accelerate drug discovery and development workflows, today announced the launch of its ...

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says Dymowski. She cites political tensions, import and export disruptions, and ...

Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

The ability to probe the smallest building blocks of matter has long fascinated scientists, fueling advancements in medicine, ...

Residents testified they were concerned about drug rehab patients wandering into Century Village late at night and breaking into condos.

The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Yuka Manabe and her team at the Center for Innovative Diagnostics for Infectious Diseases aim to improve global health with ...

Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.